STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $106,000 | -31.2% | 51,948 | 0.0% | 0.00% | – |
| Q2 2021 | $154,000 | -66.3% | 51,948 | -68.6% | 0.00% | – |
| Q1 2021 | $457,000 | +20.6% | 165,545 | +6.2% | 0.00% | – |
| Q4 2020 | $379,000 | +110.6% | 155,882 | +82.1% | 0.00% | – |
| Q3 2020 | $180,000 | -45.0% | 85,585 | -1.1% | 0.00% | – |
| Q2 2020 | $327,000 | +74.9% | 86,523 | -12.7% | 0.00% | – |
| Q1 2020 | $187,000 | -8.3% | 99,151 | +1.8% | 0.00% | – |
| Q4 2019 | $204,000 | -12.4% | 97,404 | 0.0% | 0.00% | – |
| Q3 2019 | $233,000 | -26.0% | 97,404 | -3.2% | 0.00% | – |
| Q2 2019 | $315,000 | -47.4% | 100,672 | +48.8% | 0.00% | – |
| Q1 2018 | $599,000 | +70.7% | 67,671 | +39.7% | 0.00% | – |
| Q4 2017 | $351,000 | +10.4% | 48,431 | +5.2% | 0.00% | – |
| Q3 2017 | $318,000 | -3.9% | 46,033 | -0.3% | 0.00% | – |
| Q2 2017 | $331,000 | – | 46,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
| Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
| Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
| Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
| Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
| RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
| Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
| NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
| Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
| Anson Funds Management LP | 92,219 | $221,000 | 0.07% |